CAC
LSBPW

Cowen and Company’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Cowen and Company’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-212,849
Closed -$14.1K – 358
2024
Q3 		$14.1K Sell
212,849
-19,150
-8% -$1.21K ﹤0.01% 465
2024
Q2 		$20.4K Sell
231,999
-3,534
-2% -$289 ﹤0.01% 403
2024
Q1 		$16.9K Buy
235,533
+35,213
+18% +$1.96K ﹤0.01% 458
2023
Q4 		$7.61K Buy
200,320
+221
+0.1% +$7 ﹤0.01% 423
2023
Q3 		$8.24K Buy
200,099
+100
+0.1% +$5 ﹤0.01% 477
2023
Q2 		$9.4K Buy
+199,999
New +$17K ﹤0.01% 397

Other funds holding LSBPW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $715M AUM 19.57% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Cowen and Company's LSBPW Position: Q4 2024 in Review

Cowen and Company sold out of LakeShore Biopharma Warrants (LSBPW) in Q4 2024, closing a stake of 212,849 shares — an estimated $14.1K sold.

Cowen and Company first reported a position in LSBPW in Q2 2023 and held it in 6 quarters. The position peaked at $20.4K in Q2 2024. 18 funds tracked by Wall St. Rank hold LSBPW as of Q4 2024.

  • Cowen and Company reported no remaining LakeShore Biopharma Warrants position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 212,849 LakeShore Biopharma Warrants shares in Q4 2024, an estimated $14.1K.
  • Cowen and Company first reported a position in LakeShore Biopharma Warrants in Q2 2023 and held it in 6 quarters.
  • Cowen and Company's LakeShore Biopharma Warrants position peaked at $20.4K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.